Skip to main content
NCBI home page
Oncotarget logoLink to Oncotarget
. 2017 May 8;8(19):32381. doi: 10.18632/oncotarget.17685

Correction: LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma

Gabriella Cunha Vieira, S Chockalingam, Zsombor Melegh, Alexander Greenhough, Sally Malik, Marianna Szemes, Ji Hyun Park, Abderrahmane Kaidi, Li Zhou, Daniel Catchpoole, Rhys Morgan, David O Bates, Peter J Gabb, Karim Malik
PMCID: PMC5458293  PMID: 28499332

Present: The originally supplied Figure 5 contains duplicate total-ERK panels.

Figure 5. LGR5 regulates MEK/ERK and Akt signalling.

Figure 5

Open in a new tab

Immunoblotting demonstrating A. decreases in p-ERK1/2 (T202/Y204) and p-MEK1/2 (S217/221), B. Elevated Bim-EL and C. altered Akt phosphorylation and Rictor levels accompanying LGR5 knockdown.

Correct: The proper Figure 5 appears below. The authors sincerely apologize for this error.

Original article: Oncotarget. 2015; 6:40053-67. doi: 10.18632/oncotarget.5548

Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES